Lucintel anticipates that North America will be the fastest growing region in the sepsis diagnostic market


   October 31, 2019
According to a new market report published by Lucintel, the future of the sepsis diagnostic market looks promising with opportunities in the hospitals, pathology, and reference laboratories. The sepsis diagnostic market is expected to grow with a CAGR of 9% from 2019 to 2024. The major growth drivers for this market are increasing geriatric population, development of drug-resistance among individuals, and high incidence of hospital acquired infection, and increasing number of surgical procedures.

To download report brochure, please go to https://www.lucintel.com/sepsis-diagnostic-market.aspx and click "report brochure" tab

Sepsis is a life-threatening condition caused by the response of host immune system to a bacterial infection. It causes injury to its own tissues and organs. In this market, microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers are the major technologies. Biomarker is expected to witness highest growth over the forecast period due to its various advantages in the diagnosis of sepsis and growing need for early disease diagnosis.

Within the sepsis diagnostic market, conventional diagnostic and automated diagnostic are the major methods. Automated diagnostic segment is expected to grow at the highest CAGR over forecast period.

North America will remain the largest region over the forecast period due to rise in geriatric population, infections that are incurable by antibiotics, growing adoption of advanced and new diagnostic techniques, and increasing incidences of chronic diseases.

Biomérieux, T2 Biosystems, Luminex, Becton, Dickinson (BD), Roche diagnostic, Danaher, Thermo Fisher Scientific, Bruker, Abbott, Immunexpress, Response Biomedical, Axis-Shield diagnostic, Cytosorbents, Mitsubishi Chemical, and EKF diagnostic are among the major manufacturers of sepsis diagnostic.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the sepsis diagnostic market by technology, product, pathogen, method, test type, end user, and region. Lucintel has prepared a comprehensive research report titled "Sepsis Diagnostic Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the sepsis diagnostic market by technology, product, pathogen, method, test type, end user, and region as follows:

By Technology [$M shipment analysis for 2013 – 2024]:



  • Microbiology


  • Molecular Diagnostic


  • Immunoassays


  • Flow Cytometry


  • Microfluidics


  • Biomarkers


By Product [$M shipment analysis for 2013 – 2024]:



  • Blood Culture Media


  • Assays & Reagents


  • Instruments


  • Software


By Pathogen [$M shipment analysis for 2013 – 2024]:



  • Bacterial Sepsis


  • Fungal Sepsis


  • Other Pathogens


By Test Type [$M shipment analysis for 2013 – 2024]:



  • Laboratory Tests


  • Point-of-care Tests


By End User [$M shipment analysis for 2013 – 2024]:



  • Hospitals


  • Pathology & Reference Laboratories


By Region [$M shipment analysis for 2013 – 2024]:



  • North America


    • United States


    • Canada


    • Mexico




  • Europe


    • UK


    • Germany


    • Italy




  • Asia Pacific


    • China


    • Japan


    • India




  • Rest of the World


This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/sepsis-diagnostic-market.aspx or helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.


Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [51]
Chemical [258]
Composites & Advanced Materials [159]
Construction & Industrial [68]
Consumer and Retail [120]
Economic Analysis [86]
Energy & Utility [73]
Finance & Services [10]
Healthcare [62]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [162]
Transportation [140]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on